ZURICH (Reuters) - A new drug from Roche for women with an incurable form of breast cancer is too expensive for routine use on Britain's state-run health service even after a discount, the country's healthcare cost watchdog ruled on Friday.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment